MENVEO, poudre et solution pour solution injectable. Vaccin méningococcique des groupes A, C, W-135 et Y conjugué

( ARTG ) MENVEO powder and solution for solution for injection (2 vials) MENVEO is indicated for active immunisation of infants and children (from 2 months of age), adolescents and adults to prevent invasive disease caused by Neisseria meningitidis serogroups A, C, W135 and Y. The use of this vaccine should be in accordance with official recommendations.